Main features and outcome of 8 patients with HCC
. | Case 1* . | Case 2 . | Case 3† . | Case 4 . | Case 5 . | Case 6 . | Case 7 . | Case 8 . |
---|---|---|---|---|---|---|---|---|
Hemophilia type severity‡ | A, s | A, m | B, m | A, m | A, m | A, m | A, m | B, s |
Age,§ y | 52 | 69 | 55 | 68 | 57 | 51 | 53 | 57 |
HCV type | 1b | 1b | 1a | 1a | 1b | NA | 1b | 1a |
Child-Pugh score | A | A | B | B | A | B | B | A |
Surveillance intervals, mo | 12 | 6 | 12 | 12 | 6 | 6 | 6 | 6 |
AFP level at diagnosis, ng/mL | 11 | 5 | 86 | 42 | 162 | 5 | 52 | 22 |
Number of nodules | 1 | 3 | > 10 | 5 | 6 | 7 | 5 | 3 |
Tumor size, mm | 23 | 20-30 | 5-70 | 18-30 | 6-40 | 10-40 | 8-40 | 10-20 |
Vascular invasion | No | Yes | Yes | Yes | No | Yes | No | No |
Treatment | TACE, OLT | TACE | TACE | TACE | TACE, OLT∥ | None | TACE, OLT | TACE¶ |
Survival, mo | 24 | 5 | 7 | 6 | 24 | 2 | 34 | 15 |
Outcome | Alive | Alive | Dead | Dead | Alive | Dead | Alive | Alive |
. | Case 1* . | Case 2 . | Case 3† . | Case 4 . | Case 5 . | Case 6 . | Case 7 . | Case 8 . |
---|---|---|---|---|---|---|---|---|
Hemophilia type severity‡ | A, s | A, m | B, m | A, m | A, m | A, m | A, m | B, s |
Age,§ y | 52 | 69 | 55 | 68 | 57 | 51 | 53 | 57 |
HCV type | 1b | 1b | 1a | 1a | 1b | NA | 1b | 1a |
Child-Pugh score | A | A | B | B | A | B | B | A |
Surveillance intervals, mo | 12 | 6 | 12 | 12 | 6 | 6 | 6 | 6 |
AFP level at diagnosis, ng/mL | 11 | 5 | 86 | 42 | 162 | 5 | 52 | 22 |
Number of nodules | 1 | 3 | > 10 | 5 | 6 | 7 | 5 | 3 |
Tumor size, mm | 23 | 20-30 | 5-70 | 18-30 | 6-40 | 10-40 | 8-40 | 10-20 |
Vascular invasion | No | Yes | Yes | Yes | No | Yes | No | No |
Treatment | TACE, OLT | TACE | TACE | TACE | TACE, OLT∥ | None | TACE, OLT | TACE¶ |
Survival, mo | 24 | 5 | 7 | 6 | 24 | 2 | 34 | 15 |
Outcome | Alive | Alive | Dead | Dead | Alive | Dead | Alive | Alive |